In the present study, we showed, for the first time, that erianin inhibited the proliferation, as well as the migration, invasion and apoptosis of HCC cells via the down-regulation of the PI3K/AKT and p38 and ERK MAPK pathways. The gene discussed is AKT1; the disease is hepatocellular carcinoma.